Table 1.
The clinical information of polycystic ovary syndrome (PCOS) and control subjects.
| Control | PCOS | P value | |
|---|---|---|---|
| Number | 200 | 200 | |
| Age (year) | 30.00 (28.00-33.00) | 30.00 (28.00-32.00) | 0.228 |
| BMI (kg/m2) | 23.40 (21.06-25.40) | 23.95 (20.84-28.28) | 0.064 |
| SBP (mmHg) | 120.00 (112.00-127.75) | 122.00 (113.50-132.00) | 0.101 |
| DBP (mmHg) | 76.50 (70.00-81.00) | 78.00 (70.50-84.00) | 0.173 |
| Prolactin (ng/mL) | 10.80 (7.99-14.30) | 11.00 (7.76-14.80) | 0.876 |
| FSH (mIU/ml) | 5.97 (4.71-7.30) | 5.69 (4.64-6.74) | 0.111 |
| LH (mIU/ml) | 3.29 (2.22-4.83) | 6.38 (3.73-9.89) | <0.001 |
| LH/FSH | 0.55 (0.40-0.79) | 1.05 (0.69-1.99) | <0.001 |
| Estradiol (pmol/L) | 161.00 (124.50-202.00) | 170.00 (141.00-217.00) | 0.086 |
| T (nmol/l) | 0.69 (0.69-0.70) | 0.78 (0.69-1.40) | <0.001 |
| AND (nmol/l) | 4.94 (3.47-7.21) | 8.77 (5.88-12.60) | <0.001 |
| Progesterone (nmol/L) | 0.98 (0.67-1.40) | 0.94 (0.68-1.20) | 0.577 |
| AMH (ng/ml) | 2.88 (1.78-4.28) | 7.40 (4.80-11.65) | <0.001 |
| AFC | 11.00 (9.00-14.00) | 24.00 (18.00-24.00) | <0.001 |
| FPG (mmol/L) | 5.10 (4.80-5.30) | 5.00 (4.70-5.40) | 0.415 |
| FSI (mU/L) | 6.72 (4.77-9.84) | 11.20 (7.06-17.26) | <0.001 |
| HOMA-IR | 1.57 (1.02-2.42) | 2.44 (1.51-4.04) | <0.001 |
| T-CHO (mmol/L) | 4.26 (3.79-4.81) | 4.52 (4.01-5.21) | <0.001 |
| TG (mmol/L) | 1.00 (0.73-1.48) | 1.24 (0.87-1.83) | 0.001 |
| HDL-C (mmol/L) | 1.27 (1.11-1.48) | 1.26 (1.09-1.48) | 0.913 |
| LDL-C (mmol/L) | 2.69 (2.29-3.14) | 2.95 (2.42-3.59) | 0.001 |
| Uric acid (mmol/L) | 274.00 (242.00-316.00) | 302.00 (254.00-357.00) | <0.001 |
| hsCRP (ng/ml) | 0.16 (0.13-0.27) | 0.64 (0.24-1.94) | <0.001 |
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FSH, follicle stimulating hormone; LH, luteinizing hormone; T, total testosterone; AND, androstenedione; AMH, anti-Müllerian hormone; AFC, antral follicle counting; FPG, fasting plasma glucose; FSI, fasting serum insulin; HOMA-IR, homeostasis model assessment of insulin resistance; T-CHO, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; hsCRP, high sensitivity C-reactive protein. The data were represented by the median (interquartile range). Independent sample t test and the Mann-Whitney U test were used for normally and non-normally distributed variables, respectively.